Next-Generation Sequencing Assays for Biomarker Analysis of Solid Tumors

Pioneer the path toward precision oncology—from preclinical to companion diagnostic development

The discovery of genetic biomarkers and their subsequent application in oncology research are paving the path toward targeted therapy development and selection, linking genes to disease states and prognosis, and, ultimately, more effective treatments. Our next-generation sequencing assays and bioinformatics and reporting products offer powerful options to support your efforts—from preclinical to companion diagnostic development.

Learn more from a member of our team by completing the form.

* Required field

I would like to receive information about events, products, services and promotions from Thermo Fisher Scientific and its affiliates.

By following relevant data privacy laws, Thermo Fisher Scientific will take great care in processing my personal data in line with its privacy policy, which can be reviewed at thermofisher.com/privacypolicy.

I can choose to unsubscribe at any time by e-mailing reply@thermofisher.com.